Abstract: A magnesium alloy includes about 7.2 to about 7.8 wt % aluminum, about 0.45 wt % to about 0.90 wt % zinc, about 0.17 wt % to about 0.40 wt % manganese, about 0.30 wt % to about 1.5 wt % rare earth elements, about 0.00050 wt % to about 0.0015 wt % beryllium, and the rest being magnesium and unavoidable impurities. A method of making the magnesium alloy is further provided.

Abstract: A human mutY polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for preventing and/or treating diseases associated with a mutation in this gene. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.

Abstract: The present invention discloses a projecting method from a mobile device to an on-board unit (OBU). The projection method includes steps of storing a first display frame data with a first resolution and a first color format of the OBU in a first writeback buffer; transferring the first display frame data to an OBU display; and displaying the first display frame data in the OBU display.

Abstract: A system for automatically adjusting sound effects and a method thereof. The system includes a communication module, a playing module, an input module for receiving a choice among a plurality of songs made by a user, and a processing module configured to search a storage module for one of sets of sound effects parameters corresponding to the choice made by the user. If the set of sound effects parameters corresponding to the choice made by the user is not found, the processing module is then configured to obtain the set of sound effects parameters from a plurality of servers through a communication module. The playing module is configured to adjust a playing mode according to the set of sound effects parameters found or obtained by the processing module, and to play the song of choice in the playing mode.

Abstract: The present invention discloses a method for controlling in realtime fashion multimedia contents on a second screen at a TX side from a first screen at a RX side. The method comprising: detecting at least one touch signal via the first screen, and converting the at least one touch signal into touch data associated with a first position information defining a virtual operation on the first screen corresponding to an actual operation on the second screen, the first position information being with respect to a first coordinate system of the first screen; transmitting the touch data of the RX side to the TX side via the network communication, and calculating at the TX side a second position information with respect to a second coordinate system of the second screen based on the first position information; and performing the actual operation at the second screen based on the second position information.

Abstract: A human mutY polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for preventing and/or treating diseases associated with a mutation in this gene. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.

Abstract: The present application provides multistage and multilayer reactors useful for the efficient and continuous production of carbon nanotubes and methods of using the apparatus in the preparation of carbon nanotubes. In one aspect, the multistage reactors include an array of interconnected fluidized-bed reactors. The multilayer reactors include a plurality of reaction zones.

Abstract: A human mutY polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for preventing and/or treating diseases associated with a mutation in this gene. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.

Abstract: The present application provides multistage and multilayer reactors useful for the efficient and continuous production of carbon nanotubes and methods of using the apparatus in the preparation of carbon nanotubes. In one aspect, the multistage reactors include an array of interconnected fluidized-bed reactors. The multilayer reactors include a plurality of reaction zones.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.

Abstract: The present invention concerns a member of the human chemokine CC protein family. In particular, isolated nucleic acid molecules are provided encoding the chemokine ?-15 protein. Chemokine ?-15 polypeptides are also provided. The invention further concerns diagnostic methods for detecting thymus disorders and therapeutic methods for modulating bone marrow cell proliferation and differentiation.

Abstract: The present invention discloses transforming growth factor alpha HII polypeptides and polynucleotides encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and therapeutic uses of the polypeptides which include stimulating wound healing, treating neurological disorders, treating ocular disorders, treating kidney and liver disorders, and stimulating embryogenesis and angiogenesis. Also disclosed are antagonists against such polypeptides and their use as a therapeutic to treat neoplasia. Also disclosed are diagnostic assays for detecting altered levels of the polypeptide of the present invention and mutations in the nucleic acid sequences which encode the polypeptides of the present invention.

Abstract: The present invention relates to 12 novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

Abstract: The present invention relates to a method for continuous production of carbon nanotubes in a nano-agglomerate fluidized bed, which comprises the following steps: loading transition metal compounds on a support, obtaining supported nanosized metal catalysts by reducing or dissociating, catalytically decomposing a carbon-source gas, and growing carbon nanotubes on the catalyst support by chemical vapor deposition of carbon atoms. The carbon nanotubes are 4˜100 nm in diameter and 0.5˜1000 ?m in length. The carbon nanotube agglomerates, ranged between 1˜1000 ?m, are smoothly fluidized under 0.005 to 2 m/s superficial gas velocity and 20-800 kg/m3 bed density in the fluidized-bed reactor. The apparatus is simple and easy to operate, has a high reaction rate, and it can be used to produce carbon nanotubes with high degree of crystallization, high purity, and high yield.

Abstract: Carbon-nanotube arrays, yarns, films and composites, and the methods for preparing the same are provided. The substrate used is non-flat and has a radius of curvature of at least about 10 ?m. The length of the carbon-nanotube yarns and films is at least about 1 cm. The method for preparing the carbon-nanotube composites includes the step of contacting a carbon-nanotube yarn or film with a polymer.

Abstract: The present invention relates to a method for continuous production of carbon nanotubes in a nano-agglomerate fluidized bed, which comprises the following steps: loading transition metal compounds on a support, obtaining supported nanosized metal catalysts by reducing or dissociating, catalytically decomposing a carbon-source gas, and growing carbon nanotubes on the catalyst support by chemical vapor deposition of carbon atoms. The carbon nanotubes are 4˜100 nm in diameter and 0.5˜1000 ?m in length. The carbon nanotube agglomerates, ranged between 1˜1000 ?m, are smoothly fluidized under 0.005 to 2 m/s superficial gas velocity and 20˜800 kg/m3 bed density in the fluidized-bed reactor. The apparatus is simple and easy to operate, has a high reaction rate, and it can be used to produce carbon nanotubes with high degree of crystallization, high purity, and high yield.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

Abstract: The present invention relates to a novel human gene encoding a polypeptide which is a member of the TNF receptor family, and has now been found to bind TRAIL. More specifically, an isolated nucleic acid molecule is provided encoding a human polypeptide named tumor necrosis factor receptor-5, sometimes referred to as “TNFR-5” or “TR5,” and now referred to hereinafter as “TRAIL receptor without intracellular domain” or “TRID.” TRID polypeptides are also provided, as are vectors, host cells, and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists or antagonists of TRAIL polypeptide activity. Also provided are diagnostic and therapeutic methods utilizing such compositions.

Abstract: A human mutY polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for preventing and/or treating diseases associated with a mutation in this gene. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.

Abstract: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.